Guided Therapeutics (GTHP) Receivables (2010 - 2025)
Guided Therapeutics recorded quarterly Receivables of $4000.0 in Q4 2025, down 33.33% quarter-over-quarter from $6000.0 in Q3 2025, and up 33.33% year-over-year from $3000.0 in Q4 2024.
Guided Therapeutics' Receivables history runs 16 years deep, the most recent figure standing at $4000.0 for Q4 2025.
- In Q4 2025, Receivables rose 33.33% year-over-year to $4000.0; the TTM figure through Dec 2025 stood at $4000.0 (up 33.33% YoY), while the FY2025 annual figure was $4000.0, up 33.33% from the prior year.
- Receivables came in at $4000.0 for Q4 2025 at Guided Therapeutics, down from $6000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $152.0 million in Q2 2021 to a low of $2000.0 in Q3 2024.
- A 5-year average of $7.7 million and a median of $8471.0 in 2023 frame the typical range for Receivables.
- Across the five-year window, Receivables soared 121500.0% in 2021 and plunged 99.88% in 2022, its largest moves.
- Guided Therapeutics' Receivables stood at $126000.0 in 2021, then increased by 3.96% to $130984.0 in 2022, then plunged by 94.66% to $7000.0 in 2023, then plunged by 57.14% to $3000.0 in 2024, then soared by 33.33% to $4000.0 in 2025.
- According to Business Quant data, Receivables over the past three periods registered $4000.0, $6000.0, and $8000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.09 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,047.00 |
| Mar 31, 2024 | 6,882.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 8,942.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 55,314.00 |
| Dec 31, 2022 | 130,984.00 |
| Sep 30, 2022 | 120,691.00 |
| Jun 30, 2022 | 179,831.00 |
| Mar 31, 2022 | 256,000.00 |
| Dec 31, 2021 | 126,000.00 |
| Sep 30, 2021 | 126,000.00 |
| Jun 30, 2021 | 152.00 Mn |
| Mar 31, 2021 | 126,000.00 |
| Dec 31, 2020 | 150,000.00 |
| Sep 30, 2020 | 126,000.00 |
| Jun 30, 2020 | 125,000.00 |
| Mar 31, 2020 | 124,000.00 |
| Dec 31, 2019 | 114,000.00 |
| Sep 30, 2019 | 123,000.00 |
| Jun 30, 2019 | 157,000.00 |
| Mar 31, 2019 | 157,000.00 |
| Dec 31, 2018 | 157,000.00 |
| Sep 30, 2018 | 818,000.00 |
| Jun 30, 2018 | 161,000.00 |
| Mar 31, 2018 | 244,000.00 |
| Dec 31, 2017 | 160,000.00 |
| Sep 30, 2017 | 244,000.00 |
| Jun 30, 2017 | 248,000.00 |
| Mar 31, 2017 | 244,000.00 |
| Dec 31, 2016 | 279,000.00 |
| Sep 30, 2016 | 226,000.00 |
| Jun 30, 2016 | 289,000.00 |
| Mar 31, 2016 | 230,000.00 |
| Dec 31, 2015 | 190,000.00 |
| Sep 30, 2015 | 219,000.00 |
| Jun 30, 2015 | 282,000.00 |
| Mar 31, 2015 | 358,000.00 |
| Dec 31, 2014 | 338,000.00 |
| Sep 30, 2014 | 417,000.00 |
| Jun 30, 2014 | 233,000.00 |
| Mar 31, 2014 | 122,000.00 |
| Dec 31, 2013 | 133,000.00 |
| Sep 30, 2013 | 112,000.00 |
| Jun 30, 2013 | 177,000.00 |
| Mar 31, 2013 | 166,000.00 |
| Dec 31, 2012 | 107,000.00 |
| Sep 30, 2012 | 65,000.00 |
| Jun 30, 2012 | 139,000.00 |
| Mar 31, 2012 | 38,000.00 |
| Dec 31, 2011 | 117,000.00 |
| Jun 30, 2011 | 149,000.00 |
| Dec 31, 2010 | 85,000.00 |